Artios signs research collaboration with Masaryk University to develop novel cancer treatments targeting DNA nucleases in the DDR 12 June 2017 | Press release
Artios Strengthens Management Team with the Appointment of Dr Simon Boulton as Vice President Science Strategy 2 November 2016 | Press release
Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies 21 September 2016 | Press release
